As MSK Procedure Migration to ASCs Accelerates, Hospitals, Surgeons, and Orthopedics Makers Are on the Spot

article image

Recent CMS reimbursement changes that favor migration of many common musculoskeletal procedures to outpatient settings and remove hurdles for their uptake by ambulatory surgery centers are likely to lead to new alliances among hospitals, ASCs, and surgeons, with implications for implant vendors.

2021 is shaping up to be a big year for migrating many musculoskeletal (MSK) procedures from hospitals to the outpatient (HOPD) and ambulatory surgery center (ASC) settings.

Many hospital surgery service lines have successfully migrated common procedures to outpatient settings over the past 40 years, starting with ophthalmology, gastroenterology, and ENT. Technology advances, favorable reimbursement, and changes in ASC and hospital ownership structures have aligned to encourage this trend. 


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: